Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 14th November, 2025, inter alia; 1. To consider and approve Un-audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the Quarter and Half Year ended on 30th September, 2025. 2. Any other agendas as may be considered necessary with the permission of the chair. Further, in accordance with the Company's Code of Conduct for Prevention of Insider Trading, the Company has intimated its 'designated persons' regarding the closure of the Trading Window for trading in the Company's equity shares from October 01, 2025 till the expiry of 48 hours from the date of said financial results are made public.